Europe Humanized Mice Model Market to Grow at a Formidable Rate through 2025
Rising adoption of mice
models for various research studies to drive Europe humanized mice model market
According
to TechSci Research report, “Europe
Humanized Mice Model Market By Service (Breeding, Cryopreservation,
Others), By Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice,
Others), By Immune Checkpoints (CD47, CD34, PBMC, Others), By Technology
(Crispr/Cas9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer,
Other Technologies), By Application (Oncology Studies, Immunology and
Inflammation Studies, Others), By End-use (Companies, Organizations, Academic
and Research Institutes, Contract Research Organizations), By Country, Forecast
& Opportunities, 2025”, the Europe humanized mice model market is expected to grow
at a significant rate during the forecast period on account of the increasing
number of testing procedures on mice to understand the effect of diseases in humans
such as such as diabetes, cancer and cardiovascular diseases. In addition to
this, rising demand for personalized medicines is expected to propel the market
growth over the next few years. Emergence of CRISPR as a powerful tool in the
field of biomedical research is further expected to fuel the market growth.
Moreover, there is an increase in the monoclonal antibody production, which is
further driving the market growth. However, there are certain factors that
might act as major impediments to the growth of Europe mice model market during
the forecast period such as the laws and regulations for the use of animals in
research.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on " Europe
Humanized Mice Model market"
https://www.techsciresearch.com/report/europe-humanized-mice-model-market/4828.html
The Europe humanized mice model market is segmented based on service,
type, immune checkpoints, technology, application, end use, company, company
and region. Based on end use, the market can be split into companies {pharmaceutical,
biotechnology, cosmetics}, organizations {government, non-government}, academic
and research institutes, contract research organizations). The companies’ segment
held the largest market share until 2019 and is expected to dominate the market
during the forecast period. This dominance can be attributed to growing number
of R&D activities in biotech and pharma industry. Moreover, rising number
of pipeline drugs that demand for animal testing in order to validate the
safety and efficacy of drugs are impelling the segmental growth. In addition to
this, development of novel vaccines is further contributing to the growth of
segment. Based on type, the market is fragmented into inbred mice, outbred
mice, genetically engineered mice, hybrid/congenic mice, conditioned/surgically
modified mice, spontaneous mutant mice. Out of these, the genetically
engineered mice segment is projected to dominate the market during the forecast
period on account of emergence of CRISPR technology that aids in generating
gene knockouts.
Charles River Laboratories, International, Inc., The Jackson Laboratory,
Gempharmatech Co Ltd, Taconic Biosciences, Inc., Envigo (Harlan Laboratories,
Inc.), Laboratory Corporation of America Holdings, Janvier Labs, Trans Genic,
Inc., Genoway, Creative Biolabd, Horizon Discovery Group, Ingenious Targeting
Laboratory, Biocytogen, and others are some of the leading players operating in
Europe humanized mice model market. The companies operating in the market are
coming up with new developments in order to boost their market share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4828
Customers can also request for
10% free customization on this report.
“Europe is expected to register high
growth in the humanized mice model market during the forecast period owing to upsurge
in the number of research studies related to cardiovascular diseases, cancer and
metabolic disorders. Additionally, growing elderly population in the region is
further expected to spur the market growth. Furthermore, existence of major
market players is expected to create lucrative opportunities for the market
growth over the coming years.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based Europe management consulting firm.
“Europe Humanized Mice Model Market By Service (Breeding,
Cryopreservation, Others), By Type (Inbred Mice, Outbred Mice, Genetically
Engineered Mice, Others), By Immune Checkpoints (CD47, CD34, PBMC, Others), By Technology
(Crispr/Cas9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer,
Other Technologies), By Application (Oncology Studies, Immunology and
Inflammation Studies, Others), By End-use (Companies, Organizations, Academic
and Research Institutes, Contract Research Organizations), By Country, Forecast & Opportunities, 2025”, has
evaluated the future growth potential of Europe humanized mice model market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in Europe humanized mice model market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]